Hong Kong Stock Hot Stock Analysis: Grand Health International (02211.HK)

Grand Health International (02211.HK) is a pharmaceutical retail company in the healthcare sector of the Hong Kong stock market [0]. This stock recently made it to the surge list of the East Money App hot list, but no clear fundamental catalysts or major news events driving its popularity have been found so far [0]. As a small-cap stock with a market capitalization of approximately HK$207 million, it is susceptible to speculative influences driven by short-term capital speculation and retail investor sentiment [0]. In terms of price, the current share price of HK$1.87 (as of 2025-12-02 02:46 UTC) is near its 52-week high, with a 52-week high of HK$2.47 and a low of HK$0.10 [0]. The daily trading volume was only 5,000 shares, far below the average volume of 358,871 shares [0], indicating limited market participation and that the popularity is more from short-term speculative behavior.

There is a clear divergence between the stock’s popularity and trading volume. The high price supported by low volume lacks a solid foundation, more likely a short-term fluctuation caused by retail sentiment and hot list effects. Its financial condition is poor: net profit margin is negative, ROA (-5.07%) and ROE (-9.39%) are both negative [0]; debt risk is high with an interest coverage ratio of -23.75, indicating weak debt-servicing ability [0]. Although P/B (0.47) and P/S (0.20) valuations are low, the poor financial condition offsets the valuation advantages [0].

• Main Risks
  : Sustained deterioration of financial condition, risk of debt default, difficulty in entering/exiting due to insufficient liquidity, sharp price swings caused by speculative fluctuations [0].
• Opportunities
  : Low valuation may attract the attention of value investors, but need to wait for signals of fundamental improvement [0].
• Priority Assessment
  : Financial and debt risks are high-priority concerns, followed by liquidity risks.

Grand Health International (02211.HK) recently became a hot stock in Hong Kong mainly driven by small-cap speculation and retail sentiment, lacking clear fundamental support. Its financial and debt conditions are poor, with insufficient liquidity and high short-term fluctuation risks. Investors should carefully evaluate its risk-reward ratio and pay attention to the price performance at the support level of HK$1.80 and resistance level of HK$2.47 [0].